MyFinsight
Home
Blog
About
Contact
rprx: the balance sheet
Download
Download image
Other current assets
$5,519K
(11.07%↑ Y/Y)
Other royalty income
receivable
$28,901K
(16.06%↑ Y/Y)
Available for sale debt
securities
$16,100K
(-66.80%↓ Y/Y)
Financial royalty assets
$860,073K
(12.31%↑ Y/Y)
Cash and cash
equivalents
$938,944K
(-1.17%↓ Y/Y)
Other assets
$86,585K
(102.35%↑ Y/Y)
Goodwill
$924,634K
Equity method
investments
$290,957K
(-17.11%↓ Y/Y)
Available for sale debt
securities
$302,500K
(-53.98%↓ Y/Y)
Equity securities
$129,393K
(-43.46%↓ Y/Y)
Financial royalty assets,
net
$15,763,674K
(5.32%↑ Y/Y)
Total current assets
$1,849,537K
(3.08%↑ Y/Y)
Total assets
$19,347,280K
(7.23%↑ Y/Y)
Total liabilities and
shareholders equity
$19,347,280K
(7.23%↑ Y/Y)
Total shareholders
equity
$9,620,861K
(-6.22%↓ Y/Y)
Total liabilities
$9,726,419K
(24.96%↑ Y/Y)
Treasury interests
$2,611K
(-1.73%↓ Y/Y)
Non-controlling interests
$3,206,513K
(-5.37%↓ Y/Y)
Retained earnings
$2,304,314K
(-16.65%↓ Y/Y)
Additional paid-in capital
$4,112,538K
(0.12%↑ Y/Y)
Other liabilities
$126,944K
(2174.98%↑ Y/Y)
Accrued compensation
liabilities
$502,938K
Long-term debt
$8,565,735K
(29.58%↑ Y/Y)
Total current
liabilities
$530,802K
(-54.55%↓ Y/Y)
Common stock-Class
RRedeemable Stock
$63K
(0.00%↑ Y/Y)
Common stock-Common
Class A
$44K
(-2.22%↓ Y/Y)
Other current
liabilities
$3,121K
(-90.00%↓ Y/Y)
Current portion of
long-term debt
$380,000K
(-61.88%↓ Y/Y)
Interest payable
$29,044K
(-24.39%↓ Y/Y)
Accounts payable and
accrued liabilities
$41,415K
(87.78%↑ Y/Y)
Distributions payable to
non-controlling interests
$77,222K
Back
Back
Balance Sheet
source: myfinsight.com
1-svg
Royalty Pharma plc (RPRX)
1-svg
Royalty Pharma plc (RPRX)